Pathway alteration burden derived from whole-exome sequencing is associated with survival in primary central nervous system lymphoma.
- DOI
- 10.1111/bjh.70734
- Published
- 2026 Aug 15
- Container
- British journal of haematology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/bjh.70734,
title = {Pathway alteration burden derived from whole-exome sequencing is associated with survival in primary central nervous system lymphoma.},
author = {Gui J and Yang A and Lin J and Che Q and Feng L and Lin P and Chen J and Zeng Z},
year = {2026},
journal = {British journal of haematology},
doi = {10.1111/bjh.70734},
url = {https://doi.org/10.1111/bjh.70734}
}RIS
TY - JOUR TI - Pathway alteration burden derived from whole-exome sequencing is associated with survival in primary central nervous system lymphoma. AU - Gui J AU - Yang A AU - Lin J AU - Che Q AU - Feng L AU - Lin P AU - Chen J AU - Zeng Z PY - 2026 JO - British journal of haematology DO - 10.1111/bjh.70734 UR - https://doi.org/10.1111/bjh.70734 ER -
APA
J, G., A, Y., J, L., Q, C., L, F., P, L., J, C., & Z, Z. (2026). Pathway alteration burden derived from whole-exome sequencing is associated with survival in primary central nervous system lymphoma.. British journal of haematology. https://doi.org/10.1111/bjh.70734
Source records
- pubmed · retrieved 2026-09-26T05:01:40.527Z